Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gayle P Pouliot

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nature Medicine|October 9, 2014
Thymocyte transformation enhancedGayle P Pouliot, Alejandro Gutierrez
Cell Reports|March 23, 2017
Demethylated HSATII DNA and HSATII RNA Foci Sequester PRC1 and MeCP2 into Cancer-Specific Nuclear BodiesLisa L Hall, Meg Byron, Dawn M Carone, et al.
Molecular Cancer Therapeutics|July 24, 2023
First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and LymphomaErika P Hamilton, Judy S Wang, Amit M Oza, et al.
Leukemia|April 15, 2018
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemiaMelissa A Burns, Zi Wei Liao, Natsuko Yamagata, et al.
Plos One|November 14, 2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemiaGayle P Pouliot, James Degar, Laura Hinze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid TumorsEmerson A Lim, Johanna C Bendell, Gerald S Falchook, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nature Medicine|October 9, 2014
Thymocyte transformation enhancedGayle P Pouliot, Alejandro Gutierrez
Cell Reports|March 23, 2017
Demethylated HSATII DNA and HSATII RNA Foci Sequester PRC1 and MeCP2 into Cancer-Specific Nuclear BodiesLisa L Hall, Meg Byron, Dawn M Carone, et al.
Molecular Cancer Therapeutics|July 24, 2023
First-in-human Study of AZD5153, A Small-molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and LymphomaErika P Hamilton, Judy S Wang, Amit M Oza, et al.
Leukemia|April 15, 2018
Hedgehog pathway mutations drive oncogenic transformation in high-risk T-cell acute lymphoblastic leukemiaMelissa A Burns, Zi Wei Liao, Natsuko Yamagata, et al.
Plos One|November 14, 2019
Fanconi-BRCA pathway mutations in childhood T-cell acute lymphoblastic leukemiaGayle P Pouliot, James Degar, Laura Hinze, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2022
Phase Ia/b, Open-Label, Multicenter Study of AZD4635 (an Adenosine A2A Receptor Antagonist) as Monotherapy or Combined with Durvalumab, in Patients with Solid TumorsEmerson A Lim, Johanna C Bendell, Gerald S Falchook, et al.
Pageof 1